Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.

Supporting you

We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years. 

Find out more about the MS-UK Helpline

Find out more about our Choices booklets

Find out more about New Pathways magazine

 


Symptoms of multiple sclerosis have long been linked with the body’s immune system, and immune response has also been linked to depression. Now researchers think it could be a shared pathological...
The European Commission (EC) has approved Zinbryta for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS). Zinbryta, which is being developed by Biogen and AbbVie, is a...
Individuals with genetically increased body mass indexes are at a greater risk for developing multiple sclerosis (MS), according to analyses performed on two genome-wide association datasets. For...
Roche has announced that the European Medicines Agency (EMA) has validated the company’s Marketing Authorisation Application (MAA) of ocrelizumab for the treatment of relapsing multiple sclerosis (...
The multiple sclerosis drug Gilenya may help patients by directly enhancing nerve regeneration and increasing myelination in a way that is partly independent of its anti-inflammatory properties....
Rituximab may be an possible treatment option for patients with relapsing-remitting multiple sclerosis (MS), researchers say, after phase II study findings found its efficacy in controlling...
Taste deficits appear to be more prevalent among multiple sclerosis (MS) patients than previously reported and correlate with brain lesions left, a new study from the University of Pennsylvania's...
Scientists of the Technical University of Munich (TUM) and the Max Planck Institute of Psychiatry have identified four new risk genes that are altered in German patients with multiple sclerosis (MS...
Leaky blood vessels in the brain called cerebral microbleeds are associated with increased physical and cognitive disability in patients with multiple sclerosis (MS), according to a new study by...
A radical and risky stem cell therapy has been shown to halt and even reverse some of the symptoms of those worst affected by multiple sclerosis, a condition that in many people has proved...

Pages